Science Explorer Back to mapMap
Discussion
Researcher · Abbott Fund · United States

Vincent L. Giranda

Vincent L. Giranda publishes mostly in Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as PARP inhibition in cancer therapy, DNA Repair Mechanisms and PI3K/AKT/mTOR signaling in cancer.

OpenAlex
World rank
#611,275
of 7,710,434 ranked researchers
Rank in United States
#209,343
of 1,627,098
Works
176
Citations
7.3k
Citations per work
41.3
h-index
49
i10-index 101Top 3.9% in Oncology
Vincent L. Giranda

What does Vincent L. Giranda research?

Vincent L. Giranda's work is mostly in Medicine (36%), Biochemistry, Genetics and Molecular Biology (28%), Chemistry (6%).

Health Sciences: 64 works · 36.3% of their workMedicine: 64 works · 36.3% of their workOncology: 52 works · 29.8% of their workPulmonary and Respiratory Medicine: 11 works · 6.5% of their workLife Sciences: 55 works · 31.4% of their workBiochemistry, Genetics and Molecular Biology: 49 works · 28.1% of their workMolecular Biology: 42 works · 23.7% of their workCancer Research: 8 works · 4.4% of their workImmunology and Microbiology: 6 works · 3.3% of their workImmunology: 6 works · 3.3% of their workEverything else: 46 works · 26.3% of their workPhysical Sciences: 11 works · 6.0% of their workChemistry: 11 works · 6.0% of their workOrganic Chemistry: 11 works · 6.0% of their workTHEIR WORKVincent L.Giranda176works
Life Sciences31%Physical Sciences6%Health Sciences36%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine6436.3%
    1. Biochemistry, Genetics and Molecular Biology4928.1%
    2. Immunology and Microbiology63.3%
  3. Everything else4626.3%
    1. Chemistry116.0%
  1. 1Oncology30% of their works
  2. 2Molecular Biology24% of their works
  3. 3Pulmonary and Respiratory Medicine6% of their works
  4. 4Organic Chemistry6% of their works
  5. 5Cancer Research4% of their works
  6. 6Immunology3% of their works

Research topics

Which keywords describe Vincent L. Giranda's research?

The keywords of their largest research topics: Homologous Recombination, BRCA Mutation, PARP Inhibitors, Cancer, DNA Damage, Repair, Chemotherapy and Metastasis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Homologous Recombination1032 topics
  2. BRCA Mutation731 topic
  3. PARP Inhibitors731 topic
  4. Cancer532 topics
  5. DNA Damage301 topic
  6. Repair301 topic
  7. Chemotherapy262 topics
  8. Metastasis262 topics
  9. Signaling231 topic
  10. mTOR231 topic
  11. Chemotherapy-Induced Peripheral Neuropathy161 topic
  12. Taxanes161 topic
  13. Genomic Profiles151 topic
  14. Small-Cell Lung Cancer151 topic
  15. Indirubin121 topic
  16. Quinazoline121 topic
  17. DNA111 topic
  18. Pim Oncogenes111 topic
  19. Topoisomerases111 topic
  20. Tumorigenesis111 topic

Where does Vincent L. Giranda work?

Vincent L. Giranda's main affiliation in the publication record is Abbott Fund, United States.

How many publications and citations does Vincent L. Giranda have?

OpenAlex counts 176 works and 7,273 citations for Vincent L. Giranda, an h-index of 49, ranking #611,275 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Vincent L. Giranda. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.